Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 64.0 | 60 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 78.0 | 48 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 101.5 | 68 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | RANTES | 52.0 | 54 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | RANTES | 102.5 | 66 | ||||
N2586 | EGF | 100 | ng/mL | 3 | RANTES | 103.0 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | RANTES | 166.0 | 63 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 167.0 | 43 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 177.5 | 32 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | RANTES | 75.0 | 50 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | RANTES | 136.0 | 55 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | RANTES | 171.0 | 45 | ||||
RA2159 | 3 | RANTES | 152.0 | 68 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | RANTES | 215.0 | 55 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | RANTES | 119.0 | 49 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | RANTES | 111.5 | 58 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | RANTES | 105.5 | 68 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | RANTES | 69.0 | 68 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | RANTES | 90.0 | 59 | ||||
N2586 | 3 | RANTES | 97.5 | 62 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | RANTES | 183.0 | 71 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | RANTES | 90.0 | 66 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | RANTES | 84.0 | 63 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | RANTES | 86.5 | 52 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | RANTES | 162.0 | 55 |